CMRGX | MERFX | CMRGX / MERFX | |
Total Expense Ratio | 1.91 | 1.56 | 122% |
Annual Report Gross Expense Ratio | 12.31 | 1.67 | 737% |
Fund Existence | 2 years | 37 years | - |
Gain YTD | 7.302 | 5.834 | 125% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000000 | 2500 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.6M | 2.39B | 0% |
Annual Yield % from dividends | 1.34 | 1.65 | 81% |
Returns for 1 year | 7.23 | 5.24 | 138% |
Returns for 3 years | N/A | 9.20 | - |
Returns for 5 years | N/A | 10.48 | - |
Returns for 10 years | N/A | 24.85 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPCX | 12.71 | 0.09 | +0.71% |
Saratoga Health & Biotechnology C | |||
GCINX | 15.50 | 0.06 | +0.39% |
Green Century MSCI Intl Indx Indvl Inv | |||
FCUEX | 20.32 | 0.03 | +0.15% |
NYLI PineStone U.S. Equity Class A | |||
OEGAX | 28.68 | -0.07 | -0.24% |
Invesco Discovery Mid Cap Growth A | |||
MUSBX | 36.64 | -0.13 | -0.35% |
MFS Blended Research Core Equity B |